A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
Clinical trial NCT07716098 · RECRUITING
Trial details
- NCT number
- NCT07716098
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-27
- Primary completion
- 2028-12-27
- Enrollment
- 348
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.